Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: Costimulation with IL-2 results in a highly immunogenic phenotype

Objective. CpG-oligodeoxynucleotides (CpG-ODN) have been shown to induce pr oliferation, cytokine production, and surface molecule regulation in normal and malignant human B cells. In the present study, we investigated the pot ential of CpG-ODN to induce functional high-affinity receptors in leukemic and normal B cells and the effects of costimulation with IL-2 on proliferat ion, cytokine secretion, and surface molecule regulation. Methods. Highly purified B cells from B-CLL patients and normal controls cr ere stimulated with CpG-ODN with or without IL-2, Expression of CD25 was d etermined using FACS, and the presence of high-affinity IL-2 receptors was determined by scatchard analysis. Costimulatory effects of IL-2 and CpG-ODN were investigated using proliferation assays, ELISA (IL-6, TNF-alpha), and FAGS analysis (CD80, CD86 expression). Reactivity of autologous and alloge neic T cells toward activated B-CLL cells was determined in mixed lymphocyt e reactions and interferon-gamma Elispot assays. Results, The CpG-ODN DSP30 caused a significantly stronger induction of the IL-2 receptor alpha chain in malignant as compared with normal B cells (p = 0.03). This resulted in the expression of functional high-affinity IL-2 r eceptors in B-CLL cells, but fewer numbers of receptors with Less affinity were expressed in normal R cells. Although addition of IL-2 to CpC-ODN-stim ulated cells augmented proliferation in both normal B cells and B-CLL cells , no costimulatory effect on cytokine production or surface molecule expres sion could be observed in normal B cells. In contrast, TNF-alpha and IL-6 p roduction was increased in B-CLL cells, and the expression of CD80 and CD86 was further enhanced when IL-2 was used as a costimulus. Autologous and al logeneic immune recognition of B-CLL cells stimulated with CpG-ODN and IL-2 was increased compared with B-CLL cells stimulated with CpG-ODN alone. Conclusion. Stimulation of B-CLL cells with CpG-ODN and IL-2 might be an at tractive strategy for potential immunotherapies for B-CLL patients. (C) 200 0 International Society for Experimental Hematology. Published by Elsevier Science Inc.